Healthcare tech company Omnicell (NASDAQ:OMCL) reported Q1 CY2025 results topping the market’s revenue expectations , with sales up 9.6% year on year to $269.7 million. On the other hand, ...

Automating the future of patient care. That's Omnicell's goal for its new Innovation Lab, which is opening in Austin next week. Omnicell is a health care technology company that is seeking to make ...

Updates full year 2025 non-GAAP EBITDA and non-GAAP EPS guidance FORT WORTH, Texas, May 06, 2025--(BUSINESS WIRE)--Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell," "we ...

Healthcare tech company Omnicell (NASDAQ:OMCL) reported Q1 CY2025 results topping the market’s revenue expectations , with sales up 9.6% year on year to $269.7 million. On the other hand, next quarter ...

Ratings for Omnicell OMCL were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table encapsulates their recent ratings ...

Balance Sheet As of March 31, 2025, Omnicell’s balance sheet reflected cash and cash equivalents of $387 million, total debt (net of unamortized debt issuance costs) of $341 million, and total ...

FORT WORTH, Texas (AP) — FORT WORTH, Texas (AP) — Omnicell Inc. (OMCL) on Tuesday reported a loss of $7 million in its first quarter. On a per-share basis, the Fort Worth, Texas-based company ...

Results exceed previously issued first quarter 2025 guidance for total revenues and non-GAAP EPS Updates full year 2025 non-GAAP EBITDA and non-GAAP EPS guidance Omnicell, Inc. (NASDAQ:OMCL ...

CEO Randall Lipps highlighted strong Q1 2025 performance driven by demand for Omnicell's medication management platform. Key focus areas included market share growth in inpatient and outpatient ...